Oestrogens and progestins in relation to human cancer.
D000728:Androgens / Q000502:physiology; D001941:Breast Diseases / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D002273:Carcinogens; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D045166:Estradiol Congeners / Q000627:therapeutic use / Q000633:toxicity*; D004967:Estrogens / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D045167:Progesterone Congeners / Q000633:toxicity*; D011372:Progestins / Q000378:metabolism / Q000502:physiology*; D045165:Testosterone Congeners / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000378:metabolism
D000728:Androgens; D002273:Carcinogens; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D004967:Estrogens; D045167:Progesterone Congeners; D011372:Progestins; D045165:Testosterone Congeners